FRONTLINE COMBO SPOT-ON DOG XL
Nazione: Irlanda
Lingua: inglese
Fonte: HPRA (Health Products Regulatory Authority)
Scheda tecnica
(SPC)
10-01-2015
Alcuni documenti per questo prodotto non sono attualmente disponibili, puoi inviare una richiesta al nostro servizio clienti e ti informeremo non appena saremo in grado di ottenerli.
Invia richiesta.
Invia richiesta.
Principio attivo:
FIPRONIL, METHOPRENE
Commercializzato da:
Merial Animal Health Limited
Codice ATC:
QP53AX65
INN (Nome Internazionale):
FIPRONIL, METHOPRENE
Dosaggio:
Unknown
Forma farmaceutica:
Spot On Solution
Tipo di ricetta:
POM
Gruppo terapeutico:
Canine
Area terapeutica:
Fipronil, combinations
Indicazioni terapeutiche:
Ectoparasiticide
Stato dell'autorizzazione:
Authorised
Data dell'autorizzazione:
2004-05-14
Scheda tecnica
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Frontline Combo Spot-on Dog XL.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each pipette of 4.02 ml contains:
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Spot-on solution.
Clear amber solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of dogs weighing over 40 kg bodyweight:
-
To be used against infestations with fleas, alone or in association with ticks and/or biting lice.
-
Treatment of flea infestations (_Ctenocephalides _spp.). Insecticidal efficacy against new infestations with adult fleas
persists for 8 weeks. Prevention of the multiplication of fleas by inhibiting the development of eggs (ovicidal activity)
and larvae and pupae (larvicidal activity) originating from eggs laid by adult fleas for eight weeks after application.
-
Treatment of tick infestations (_Ixodes ricinus_, _Dermacentor variabilis_, _Dermacentor reticulatus_, _Rhipicephalus_
_sanguineus_). The product has a persistent acaricidal efficacy for up to 4 weeks against ticks.
-
Treatment of infestations with biting lice (_Trichodectes canis_).
The product can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis (FAD).
4.3 CONTRAINDICATIONS
In the absence of available data, the product should not be used on puppies less than 8 weeks old.
DO NOT USE IN RABBITS, AS ADVERSE REACTIONS WITH EVEN MORTALITY COULD OCCUR. In absence of studies, the use of the
product is not recommended in non-target species.
Do not use on sick (e.g. systemic diseases, fever) or convalescent animals.
This product is specifically developed for dogs. Do not use in cats and ferrets, as this could lead to overdosing.
Fipronil
Leggi il documento completo
